Entering text into the input field will update the search result below

Fulcrum Therapeutics, Inc. (FULC) CEO Robert Gould on Q4 2019 Results - Earnings Call Transcript

Mar. 05, 2020 2:21 PM ETFulcrum Therapeutics, Inc. (FULC)
SA Transcripts profile picture
SA Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2019 Earnings Conference Call March 5, 2020 8:00 AM ET

Company Participants

Christi Waarich - Director of Investor Relations and Corporate Communications

Robert Gould - President and Chief Executive Officer

Owen Wallace - Chief Scientific Officer

Bryan Stuart - Chief Operating Officer

Diego Cadavid - Senior Vice President of Clinical Development

Conference Call Participants

Matthew Harrison - Morgan Stanley

Joseph Schwartz - SVB Leerink

Tazeen Ahmad - Bank of America


Good morning and welcome to the Fulcrum Therapeutics Fourth Quarter and Full Year 2019 Conference Call. Currently, all participants are in listen-only mode. There will be a question-and-answer session at the end of this call.

I would now like to turn the call over to Christi Waarich, Director of Investor Relations and Corporate Communications of Fulcrum. Please proceed.

Christi Waarich

Thank you, Jimmy. Good morning. Welcome to Fulcrum Therapeutics conference call to discuss our fourth quarter and full year 2019 financial results and recent corporate highlights. Earlier today we issued a press release. For those of you who don't have a copy, you can access it in the investor relations section of our website at fulcrumtx.com.

Please be reminded that remarks made during this call may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development timelines, and financial projections. While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the future. We may update these statements in the future, but we are not taking on an obligation to do so. Please refer to our most recent filing for the Securities and Exchange Commission for a discussion of certain risks and uncertainties associated with our business.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.